Gerald W Prager (Gerald Prager)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Therapeutic advances in medical oncology

International journal of cancer

Medical oncology (Northwood, London, England)

Wiener klinische Wochenschrift

Medical University of Vienna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Vienna

Austria

Associate Professor :: Department of Medicine

University of California, San Diego

United States

Postdoctoral Fellow :: Department of Medicine

Publications

Aysegül Ilhan-Mutlu, Hannah Christina Puhr, Luzia Berchtold, Linda Zingerle, Melanie Felfernig, Lisa Weissenbacher, Gerd Jomrich, Reza Asari, Sebastian F Schoppmann, Gerald W Prager, Elisabeth S Bergen, Anna Sophie Berghoff, Matthias Preusser
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort. Wiener klinische Wochenschrift (2024)
Hossein Taghizadeh, Yawen Dong, Thomas Gruenberger, Gerald W Prager
Perioperative and palliative systemic treatments for biliary tract cancer. Therapeutic advances in medical oncology 16 (2024)
Hossein Taghizadeh, Yawen Dong, Thomas Gruenberger, Gerald W Prager
Perioperative and palliative systemic treatments for biliary tract cancer. Therapeutic advances in medical oncology 16 (2024)
Josep Tabernero, Takayuki Yoshino, Sebastian Stinzing, Aimery deGramont, Peter Gibbs, Derek J Jonker, Peter Nygren, Christos A Papadimitriou, Gerald W Prager, Roger Tell, Heinz-Josef Lenz
A Randomized Phase III Study of Arfolitixorin Versus Leucovorin with 5-Fluorouracil, Oxaliplatin and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial. Cancer research communications (2023)
Hannah Christina Puhr, Clemens C Weirauch, Flora Selimi, Karin Oberreiter, Martin A Dieterle, Gerd Jomrich, Sebastian F Schoppmann, Gerald W Prager, Anna Sophie Berghoff, Matthias Preusser, Ayseguel Ilhan-Mutlu
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma. Journal of cancer research and clinical oncology (2023)
Gilles Manceau, Thomas Seufferlein, Michele Reni, Daniel H Palmer, John A Bridgewater, Antonio Cubillo, Gerald W Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC cancer 23 (1) (2023)
Elisabeth L Zeilinger, Simone Lubowitzki, Matthias Unseld, Carmen Schneckenreiter, Daniel Heindl, Philipp B Staber, Markus Raderer, Peter Valent, Sabine Zöchbauer-Müller, Rupert Bartsch, Gerald W Prager, Ulrich Jaeger, Alexander Gaiger
The impact of COVID-19 on cancer care of outpatients with low socioeconomic status. International journal of cancer 151 (1) (2022)
Matthias Unseld, Jelena Belic, Kerstin Pierer, Qing Zhou, Tina Moser, Raimund Bauer, Gudrun Piringer, Armin Gerger, Alexander Siebenhüner, Michael R Speicher, Ellen Heitzer, Gerald W Prager
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. International journal of cancer 148 (6) (2020)
Markus Kieler, Matthias Unseld, Johann Wojta, Alexandra Kaider, Daniela Bianconi, Svitlana Demyanets, Gerald W Prager
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Medical oncology (Northwood, London, England) 36 (1) (2018)

Gerald W Prager.css-eqlu8i{font-size:small;padding-left:4px;} (Gerald Prager)

Publication Activity (10 Years)

Top Topics

Top Venues

Gerald W Prager (Gerald Prager)